Showing results (2131-2140 of 2,175) with videos related to
Sort By:
Pageof 218
Clinical Lung Cancer|February 20, 2024
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology NetworkYohann Pilon, Merav Rokah, Joseph Seitlinger, et al.The Journal of Clinical Investigation|January 22, 2020
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombinationBenjamin C Chandler, Leah Moubadder, Cassandra L Ritter, et al.Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samplesJennifer R Hamilton, Elizabeth C Stahl, Connor A Tsuchida, et al.Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.Open Forum Infectious Diseases|July 20, 2023
Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIVMolly L Hirsh, Jonathan A Edwards, Chad Robichaux, et al.Critical Care Explorations|July 17, 2023
Development and Validation of an ICU Delirium Playbook for Provider EducationHirsh Makhija, Janelle M Fine, Daniel Pollack, et al.Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.The New England Journal of Medicine|June 4, 2013
Crizotinib versus chemotherapy in advanced ALK-positive lung cancerAlice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, et al.The Lancet. Oncology|April 17, 2016
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trialKeunchil Park, Eng-Huat Tan, Ken O'Byrne, et al.Pageof 218